By Sid Ruttala For most of the past twenty years, owning BHP Group Limited (ASX: BHP) meant owning iron ore. Everything else was a portfolio garnish. Investors could argue about copper, coal, oil or potash, but the cash came out of the Pilbara and everyone knew it....
Australian Equities
CSL FY26: A US$2.6 Billion Loss, a 17 Per Cent Rally, and What the Market Actually Bought
By Sid Ruttala Large cap investing produces very few moments where the reported number and the share price move in opposite directions with such conviction. On 18 August, CSL Limited (ASX: CSL) reported a statutory net loss after tax of US$2.6 billion, the worst...
A Low Bar and a Nervous Market: What to Expect from the August Reporting Season
By Sid Ruttala Large cap investing is rarely about finding the most exciting story in the market. More often, it is about understanding what is already priced in, what is being underestimated, and whether the business can keep compounding through the noise. August is...
A Gold Boom It Did Not Fully Capture: What Is Actually Priced Into Northern Star
Large cap investing is rarely about finding the most exciting story in the market. More often it is about working out what is already priced in, what is being underestimated, and whether the business can keep compounding through the noise. Every so often the market...
Cheap Is Not a Strategy: Why a Low Price on Its Own Never Made Anyone Money
One of the most expensive words in small cap investing is cheap. It sounds like a reason to buy. It feels like a reason to buy. A stock trades at a five year low, the price to earnings multiple looks absurd next to its history, the dividend yield jumps off the screen,...
What To Expect From The Federal Budget: A Calm Walk Through What Matters For Investors
Investing is rarely about finding the most exciting story in the market. More often, it is about understanding what is already priced in, what is being underestimated, and whether the businesses and assets in your portfolio can keep compounding through the noise....
The Ozempic moment for SaaS
Written by Ron Shamgar The Ozempic moment for SaaS refers to a pivotal disruption scenario where a transformative technology threatens to erode or fundamentally reshape an established market leader's core business model, much like the hype around Ozempic (and other...
The Reawakening of Small and Mid Caps
Written by Ron Shamgar After two years of relative underperformance, Australian small and mid caps are finally showing signs of life. With inflation easing, rate cuts now on the horizon, and investor sentiment gradually shifting back toward growth, we believe the next...
The Energy Reality Check: Tariffs, Transition Fatigue, and the Repricing of Industrial Giants
As the global energy puzzle grows more complex, investors are confronting a critical inflection point: the economic cost of the energy transition is rising, public patience is thinning, and traditional industrial titans are bearing the brunt of an increasingly...
Trust in Rust: Why Industrial Stocks Are Gearing Up for a Renaissance
There are moments in markets where the noise becomes so loud, it drowns out common sense. Tariffs, geopolitics, inflation, central banks, and a US Congress with a taste for budgetary excess. And yet, despite all the reasons to panic, a certain type of company is...
EROAD: From Grit to Growth – A Telematics Turnaround Worth Watching
In a market environment where capital is scarce and investors are hunting for profitable, cash-generative growth stories, EROAD Limited (ASX/NZX: ERD) has emerged from the shadows. The company's FY25 results mark a turning point, not just for its financials, but for...
The Rise of AI Tokens and Three ASX Small Caps Ready to Ride the Wave
AI Tokens, Data Demand, and the Small Cap Opportunity Artificial intelligence is no longer confined to research labs or theoretical discussions, it's already reshaping global industries. At the core of this revolution are AI tokens, units of data that fuel the...












